Jet Life Penny Stocks
Last Post: 08/08/2025 12:43:42 PM
Board Marks: 68
Posts Today: 2
Board Views Today: 1068
03/09/2021 8:28:37 AM
03/09/2021 8:07:25 AM
03/09/2021 8:05:28 AM
03/09/2021 8:02:10 AM
03/09/2021 8:02:03 AM
03/09/2021 7:49:21 AM
03/09/2021 7:31:18 AM
03/09/2021 5:37:39 AM
03/08/2021 3:31:00 PM
03/08/2021 3:22:30 PM
03/08/2021 3:12:04 PM
03/08/2021 2:50:52 PM
03/08/2021 2:42:13 PM
03/08/2021 2:42:03 PM
03/08/2021 2:37:19 PM
03/08/2021 2:34:02 PM
03/08/2021 2:16:22 PM
03/08/2021 2:05:57 PM
03/08/2021 1:26:10 PM
03/08/2021 12:13:04 PM
03/08/2021 12:10:11 PM
03/08/2021 12:05:53 PM
03/08/2021 12:00:16 PM
03/08/2021 11:49:29 AM
03/08/2021 11:35:02 AM
03/08/2021 11:21:35 AM
03/08/2021 11:11:35 AM
03/08/2021 11:07:47 AM
03/08/2021 11:06:25 AM
03/08/2021 11:01:34 AM
03/08/2021 10:46:01 AM
03/08/2021 10:37:03 AM
03/08/2021 10:26:43 AM
03/08/2021 10:02:23 AM
03/08/2021 9:55:08 AM
03/08/2021 9:51:29 AM
03/08/2021 9:35:30 AM
03/08/2021 9:20:14 AM
03/08/2021 9:16:08 AM
03/08/2021 9:02:45 AM
03/08/2021 8:59:15 AM
03/08/2021 8:56:31 AM
03/08/2021 8:53:16 AM
03/08/2021 8:46:37 AM
03/08/2021 8:45:48 AM
03/08/2021 8:33:22 AM
03/08/2021 8:17:16 AM
03/08/2021 8:12:17 AM
03/08/2021 8:07:26 AM
03/08/2021 5:49:44 AM
Recent Articles
- Duolingo Enhances AI Strategy with Strong Quarterly Results
- Viasat's Financial Rebound: A Game-Changer for Investors
- Michael Saylor Highlights Bitcoin's Tariff-Free Advantage
- Capricor Therapeutics Faces Class Action Amid FDA Challenges
- Class Action Lawsuit Filed for PepGen Inc. Shareholders
- Hims & Hers Health Investors Encouraged to Act Now for Rights
- Legal Action Against Fiserv, Inc. for Alleged Securities Fraud
- Altimmune Faces Class Action Lawsuit: Key Details Enclosed
- Biohaven Ltd Faces Class Action Lawsuit - What Investors Should Know
- Investors of iRobot Corporation: Your Chance for Recovery
- Understanding Recent Legal Challenges Faced by Lineage, Inc.
- Cryptocurrency Overview: Bitcoin, Ethereum, and the Golden Cross
- Investors Encouraged to Act Following Lockheed Martin Lawsuit
- Replimune Group, Inc. Shareholder Rights Information
- Banco Comercial Português Updates Share Buy-Back Programme
- Join the Centene Class Action: Deadline Approaching Soon
- Banco Comercial Português Reports on Share Buy-Back Transactions
- John Hancock Closed-End Funds: A Deep Dive into Earnings
- Understanding First BanCorp's Short Interest Changes
- Understanding Investor Sentiment Towards Regeneron Pharmaceuticals
- Understanding Short Interest Trends in Northrop Grumman
- Transform Your Investment: $1000 in Zscaler's Journey
- Palatin Technologies Executes Reverse Stock Split to Align Stock Price
- Historic Firearm of Simón Bolívar to Be Auctioned Soon
- Biglari Holdings Reports Solid Second Quarter Financials
- Salama Reports Strong H1 2025 Financial Growth and Strategies
- Marex Group Faces Challenges as Investor Concerns Grow
- PetSmart Announces New Notes Offering for Financial Growth
- CleanSpark's Q3 Performance: Revenue Surge Amid Stock Drop
- John Hancock Funds Announce Impressive Earnings Results
- Join the Class Action Against Alto Neuroscience Today
- Dover Corporation Announces Increased Quarterly Dividend
- Investors Take Action: Class Lawsuit Involving 3D Systems
- Westwood Holdings Achieves Notable Growth in Latest Earnings
- RJM & Company Explores New Opportunities at Steel Summit 2025
- Vestis Corporation Faces Class Action Lawsuit: Key Insights
- NI Holdings, Inc. Releases Second Quarter Financial Insights
- Brookfield Property Partners Affirms Commitment with Dividends
- Olivia Lowery Named to Influential NCBA Family Law Committee
- Groundbreaking Achievements at Calidi Biotherapeutics Unfold
- Sarepta Therapeutics Faces Potential Class Action Lawsuit Risks
- Barnes & Noble Education Addresses Compliance with NYSE Standards
- Investors of XPLR Infrastructure, LP Could Join Class Action
- Arcutis Biotherapeutics Announces New Stock Grants to Employees
- Unlocking the Growth of $1000 in Carlisle Companies Shares
- Brookfield Property Partners Announces Quarterly Dividends Update
- DoorDash's Impactful Financials Show Path To Future Success
- Outdoor Holding Company Sees Growth Amid Challenges in Q1 2026
- Compass Therapeutics to Reveal Financial Insights on Q2 Performance
- Compass Therapeutics Set to Share Financial Insights Soon
